澳洋健康
(002172)
| 流通市值：21.81亿 | | | 总市值：21.82亿 |
| 流通股本：7.65亿 | | | 总股本：7.66亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,623,745,504.62 | 1,063,775,243.53 | 543,869,982.7 | 2,021,311,317.17 |
| 营业收入 | 1,623,745,504.62 | 1,063,775,243.53 | 543,869,982.7 | 2,021,311,317.17 |
| 二、营业总成本 | 1,567,851,006.21 | 1,023,886,303.38 | 524,020,913.92 | 2,016,300,426.61 |
| 营业成本 | 1,397,580,622.77 | 910,841,657.95 | 472,812,435.75 | 1,739,544,540.18 |
| 税金及附加 | 8,204,675.79 | 5,300,133.32 | 2,596,192 | 11,558,091.05 |
| 销售费用 | 36,789,275.31 | 25,874,291.05 | 10,889,368.64 | 44,805,889.95 |
| 管理费用 | 97,560,377.11 | 65,043,323.84 | 33,946,223.02 | 155,423,443.86 |
| 研发费用 | 1,688,589.75 | 1,147,695.46 | - | - |
| 财务费用 | 26,027,465.48 | 15,679,201.76 | 3,776,694.51 | 64,968,461.57 |
| 其中:利息费用 | 31,416,628.51 | 22,498,623.59 | 10,406,798.66 | 78,035,069.83 |
| 其中:利息收入 | 21,205,056.13 | 16,230,109.88 | 11,774,694.67 | 19,036,787.43 |
| 加:投资收益 | 22,732,355.81 | 22,635,812.93 | 25,827,820.99 | -15,886,459.31 |
| 资产处置收益 | 31,463.34 | -1,961.05 | -7,048.33 | -10,522.98 |
| 资产减值损失(新) | - | - | - | 36,009.17 |
| 信用减值损失(新) | 591,498.12 | 7,194,308.75 | -4,972,320.57 | 14,992,461.87 |
| 其他收益 | 1,615,134.69 | 1,055,882.78 | 409,510.22 | 4,182,427.41 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 80,864,950.37 | 70,772,983.56 | 41,107,031.09 | 8,324,806.72 |
| 加:营业外收入 | 5,697,901.03 | 1,882,870.46 | 948,417.77 | 14,753,589.85 |
| 减:营业外支出 | 23,729,540.31 | 22,773,362.94 | 856,072.42 | 24,042,647.82 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 62,833,311.09 | 49,882,491.08 | 41,199,376.44 | -964,251.25 |
| 减:所得税费用 | 22,881,135.82 | 14,046,180.25 | 4,540,878.64 | 14,793,007.15 |
| 六、净利润 | 39,952,175.27 | 35,836,310.83 | 36,658,497.8 | -15,757,258.4 |
| 持续经营净利润 | 39,952,175.27 | 35,836,310.83 | 36,658,497.8 | -15,757,258.4 |
| 归属于母公司股东的净利润 | 39,667,231.19 | 35,465,167.67 | 36,326,684.73 | -15,389,790.15 |
| 少数股东损益 | 284,944.08 | 371,143.16 | 331,813.07 | -367,468.25 |
| (一)基本每股收益 | 0.05 | 0.05 | 0.05 | -0.02 |
| (二)稀释每股收益 | 0.05 | 0.05 | 0.05 | -0.02 |
| 九、综合收益总额 | 39,952,175.27 | 35,836,310.83 | 36,658,497.8 | -15,757,258.4 |
| 归属于母公司股东的综合收益总额 | 39,667,231.19 | 35,465,167.67 | 36,326,684.73 | -15,389,790.15 |
| 归属于少数股东的综合收益总额 | 284,944.08 | 371,143.16 | 331,813.07 | -367,468.25 |
| 公告日期 | 2023-10-25 | 2023-08-26 | 2023-04-29 | 2023-03-24 |
| 审计意见(境内) | | | | 标准无保留意见 |